down arrow

Aurobindo Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,095.40
37.45 (3.54%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.81 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
29,001.87
24,855.38
23,455.49
24,774.63
23,098.50
19,563.55
16,232.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
266.97
Total Operating income
29,001.87
24,855.38
23,455.49
24,774.63
23,098.50
19,563.55
16,499.84
Raw Material Cost
10,776.14
9,652.51
7,371.83
8,317.27
7,724.98
7,444.99
5,629.37
Purchase of Finished goods
2,772.93
2,050.43
1,951.77
2,315.42
2,112.11
1,943.20
1,605.88
(Increase) / Decrease In Stocks
-946.17
-409.68
816.68
-730.21
-101.86
-675.55
-482.51
Employee Cost
3,922.94
3,522.25
3,450.92
3,535.02
3,219.18
2,584.87
2,130.84
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
3,827.74
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
6,633.03
6,321.23
5,477.52
6,003.72
5,319.49
4,374.38
16.76
Total Expenditure (Excl Depreciation)
23,158.87
21,136.74
19,068.72
19,441.22
18,273.90
15,671.89
12,728.08
Operating Profit (PBDIT) excl Other Income
5,843.00
3,718.64
4,386.77
5,333.41
4,824.60
3,891.66
3,771.76
Other Income
557.38
290.59
320.35
380.84
86.20
115.66
101.98
Operating Profit (PBDIT)
6,400.38
4,009.23
4,707.12
5,714.25
4,910.80
4,007.32
3,873.74
Interest
289.71
140.48
48.64
74.49
159.77
162.66
77.71
Exceptional Items
-191.86
0.00
-127.97
2,814.58
-26.13
-88.06
0.00
Gross Profit (PBDT)
5,918.81
3,868.75
4,530.51
8,454.34
4,724.90
3,756.60
3,796.03
Depreciation
1,521.66
1,244.58
1,126.52
1,055.38
966.71
667.95
557.97
Profit Before Tax
4,397.15
2,624.17
3,403.99
7,398.96
3,758.19
3,088.65
3,238.06
Tax
1,211.02
684.85
725.63
2,009.77
913.51
726.85
818.28
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,186.13
1,939.32
2,678.36
5,389.19
2,844.68
2,361.80
2,419.78
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,186.13
1,939.32
2,678.36
5,389.19
2,844.68
2,361.80
2,419.78
Share in Profit of Associates
-17.16
-11.67
-31.25
-55.36
-15.17
2.70
3.14
Minority Interest
4.00
-0.15
1.04
1.02
1.46
0.23
0.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,172.97
1,927.50
2,648.15
5,334.85
2,830.97
2,364.73
2,423.18
Equity Capital
58.59
58.59
58.59
58.59
58.59
58.59
58.59
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
29,784.21
26,781.26
24,517.39
21,871.27
16,766.07
13,832.19
11,621.83
Earnings per share (EPS)
54.16
32.9
45.2
91.05
48.32
40.36
41.36
Diluted Earnings per share
54.16
32.9
45.19
91.04
48.32
40.36
41.36
Operating Profit Margin (Excl OI)
20.36%
15.11%
18.77%
21.72%
21.22%
20.24%
22.86%
Gross Profit Margin
20.62%
15.72%
19.39%
34.43%
20.78%
19.54%
23.01%
PAT Margin
11.04%
7.83%
11.33%
21.72%
12.44%
12.3%
14.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 16.68% vs 5.97% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 64.62% vs -27.21% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 57.13% vs -15.23% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 106.23% vs 188.82% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of Aurobindo Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
29,001.87
10,334.77
18,667.10
180.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
29,001.87
10,334.77
18,667.10
180.62%
Raw Material Cost
10,776.14
1,853.52
8,922.62
481.39%
Purchase of Finished goods
2,772.93
1,409.85
1,363.08
96.68%
(Increase) / Decrease In Stocks
-946.17
-53.67
-892.50
-1,662.94%
Employee Cost
3,922.94
2,274.73
1,648.21
72.46%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
6,633.03
2,315.28
4,317.75
186.49%
Total Expenditure (Excl Depreciation)
23,158.87
7,799.71
15,359.16
196.92%
Operating Profit (PBDIT) excl Other Income
5,843.00
2,535.06
3,307.94
130.49%
Other Income
557.38
280.86
276.52
98.45%
Operating Profit (PBDIT)
6,400.38
2,815.92
3,584.46
127.29%
Interest
289.71
33.53
256.18
764.03%
Exceptional Items
-191.86
0.00
-191.86
Gross Profit (PBDT)
5,918.81
2,782.39
3,136.42
112.72%
Depreciation
1,521.66
398.25
1,123.41
282.09%
Profit Before Tax
4,397.15
2,384.14
2,013.01
84.43%
Tax
1,211.02
457.58
753.44
164.66%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
3,186.13
1,926.56
1,259.57
65.38%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
3,186.13
1,926.56
1,259.57
65.38%
Share in Profit of Associates
-17.16
15.21
-32.37
-212.82%
Minority Interest
4.00
-28.87
32.87
113.86%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,172.97
1,912.90
1,260.07
65.87%
Equity Capital
58.59
40.06
18.53
46.26%
Face Value
1.00
1.00
0.00
Reserves
29,784.21
9,323.03
20,461.18
219.47%
Earnings per share (EPS)
54.16
47.75
6.41
13.42%
Diluted Earnings per share
54.16
47.68
6.48
13.59%
Operating Profit Margin (Excl OI)
20.36%
24.53%
0.00
-4.17%
Gross Profit Margin
20.62%
26.92%
0.00
-6.30%
PAT Margin
11.04%
18.79%
0.00
-7.75%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 29,001.87 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 16.68% vs 5.97% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 3,172.97 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 64.62% vs -27.21% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5,843.00 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 57.13% vs -15.23% in Mar 2023

Annual - Interest
Interest 289.71 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 106.23% vs 188.82% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.36%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023